First Time Loading...

Yantai Zhenghai Bio-Tech Co Ltd
SZSE:300653

Watchlist Manager
Yantai Zhenghai Bio-Tech Co Ltd Logo
Yantai Zhenghai Bio-Tech Co Ltd
SZSE:300653
Watchlist
Price: 23.61 CNY 2.7% Market Closed
Updated: May 5, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Yantai Zhenghai Bio-Tech Co Ltd

Wall Street analysts forecast Yantai Zhenghai Bio-Tech Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Yantai Zhenghai Bio-Tech Co Ltd is 33.23 CNY with a low forecast of 28.28 CNY and a high forecast of 39.01 CNY.

Lowest Forecast
Wall Street Target
28.28 CNY
20% Upside
Average Forecast
Wall Street Target
33.23 CNY
41% Upside
Highest Forecast
Wall Street Target
39.01 CNY
65% Upside
Lowest
Price Target
28.28 CNY
20% Upside
Average
Price Target
33.23 CNY
41% Upside
Highest
Price Target
39.01 CNY
65% Upside
Yantai Zhenghai Bio-Tech Co Ltd Competitors:
Price Targets
GNS
Genus PLC
47% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
14% Upside
TWST
Twist Bioscience Corp
2% Upside
BIOCON
Biocon Ltd
6% Downside
GNS
Genus PLC
47% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
14% Upside
TWST
Twist Bioscience Corp
2% Upside
BIOCON
Biocon Ltd
6% Downside
301047
Sino Biological Inc
48% Upside
M
MAB
Mabion SA
3% Downside
CIR
Circassia Group PLC
29% Upside
M
086900
Medy Tox Inc
73% Upside

Revenue
Forecast

Revenue Estimate
Yantai Zhenghai Bio-Tech Co Ltd

For the last 8 years the compound annual growth rate for Yantai Zhenghai Bio-Tech Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is 20%.

16%
Past Growth
20%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Yantai Zhenghai Bio-Tech Co Ltd

For the last 8 years the compound annual growth rate for Yantai Zhenghai Bio-Tech Co Ltd's operating income is 22%. The projected CAGR for the next 2 years is 47%.

22%
Past Growth
47%
Estimated Growth
Estimates Accuracy
-11%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Yantai Zhenghai Bio-Tech Co Ltd

For the last 8 years the compound annual growth rate for Yantai Zhenghai Bio-Tech Co Ltd's net income is 21%. The projected CAGR for the next 3 years is 20%.

21%
Past Growth
20%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Yantai Zhenghai Bio-Tech Co Ltd's stock price target?
Price Target
33.23 CNY

According to Wall Street analysts, the average 1-year price target for Yantai Zhenghai Bio-Tech Co Ltd is 33.23 CNY with a low forecast of 28.28 CNY and a high forecast of 39.01 CNY.

What is Yantai Zhenghai Bio-Tech Co Ltd's Revenue forecast?
Projected CAGR
20%

For the last 8 years the compound annual growth rate for Yantai Zhenghai Bio-Tech Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is 20%.

What is Yantai Zhenghai Bio-Tech Co Ltd's Operating Income forecast?
Projected CAGR
47%

For the last 8 years the compound annual growth rate for Yantai Zhenghai Bio-Tech Co Ltd's operating income is 22%. The projected CAGR for the next 2 years is 47%.

What is Yantai Zhenghai Bio-Tech Co Ltd's Net Income forecast?
Projected CAGR
20%

For the last 8 years the compound annual growth rate for Yantai Zhenghai Bio-Tech Co Ltd's net income is 21%. The projected CAGR for the next 3 years is 20%.

ALPHA SPREAD
Join more than 134,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.